REVOFIL AQUASHINE BR SOFT FILLER – 2 Pre-Filled Syringes

REVOFIL AQUASHINE BR SOFT FILLER Product Summary

REVOFIL AQUASHINE BR SOFT FILLER is a multi-functional dermal filler combining non-animal, cross-linked hyaluronic acid with advanced peptide technology. This innovative formula is designed to address skin rejuvenation, hydration, and pigmentation concerns. The filler enhances skin elasticity, smooths fine lines, and promotes an even, radiant complexion.

• Type: Hyaluronic acid-based dermal filler with peptides.
• Purpose: Skin rejuvenation, hydration, and brightening.
• Packaging: Pre-filled syringes containing 1 mL of product, provided in sterile packaging.

REVOFIL AQUASHINE BR SOFT FILLER Key Features and Benefits

This advanced filler offers unique benefits for comprehensive skin improvement.

• Hydration: Provides deep, long-lasting moisture to the skin.
• Brightening Effect: Reduces pigmentation for a radiant, even complexion.
• Collagen Stimulation: Boosts the production of endogenous collagen and elastin.
• Enhanced Durability: Features peptide technology to resist enzymatic degradation, prolonging its effects.
• Antioxidant Protection: Neutralizes oxidative stress and UV-induced damage.

REVOFIL AQUASHINE BR SOFT FILLER Composition

The formulation combines cross-linked hyaluronic acid with bioactive peptides for enhanced efficacy.

• Active Ingredients:
  • Hyaluronic Acid Concentration: 23 mg/mL, non-animal derived.
  • Peptides:
    • Oligopeptide-72 (CG-Boostrin): Inhibits hyaluronidase for enhanced gel longevity.
    • Oligopeptide-50 (CG-Glamerin): Stimulates collagen and hyaluronic acid production.
• Additional Benefits: Monophasic gel for smooth, even application.

REVOFIL AQUASHINE BR SOFT FILLER Intended Purpose / Indications

This filler is designed for patients seeking comprehensive skin rejuvenation with added benefits of hydration and pigmentation correction.

• Primary Indications:
  • Fine lines and wrinkles.
  • Dull, dehydrated skin.
  • Pigmentation irregularities and uneven skin tone.
• Additional Benefits:
  • Improves elasticity and skin firmness.

REVOFIL AQUASHINE BR SOFT FILLER Injection and Treatment Areas

The product is suitable for superficial and mid-dermal applications, offering versatile treatment options.

• Recommended Treatment Areas:
  • Facial skin for hydration and brightening.
  • Neck and décolleté for elasticity improvement.
  • Hands for rejuvenation.
• Injection Depth: Superficial to mid-dermis for optimal results.

REVOFIL AQUASHINE BR SOFT FILLER Reconstitution and Preparation Guidelines

The filler is pre-filled and requires no reconstitution, ensuring convenience and ease of use.

• Preparation Steps:
  • Open the sterile packaging in an aseptic environment.
  • Attach the provided needle securely to the syringe.
  • Inspect the product for clarity and consistency before use.

REVOFIL AQUASHINE BR SOFT FILLER Administration and Dosage

Proper administration techniques are crucial for achieving desired results while minimizing risks.

• Injection Techniques:
  • Micro-injections or linear threading techniques for even distribution.
  • Massage the treated area gently to ensure smooth product integration.
• Dosage:
  • Typically, 1 mL per session, adjusted to the treatment area and patient needs.

REVOFIL AQUASHINE BR SOFT FILLER Storage Instructions

Proper storage ensures product stability and efficacy.

• Store between 2–25°C in a cool, dry place.
• Protect from direct sunlight and freezing conditions.
• Verify the expiration date before use.

REVOFIL AQUASHINE BR SOFT FILLER Contraindications

This product is not suitable for all patients and should be avoided in certain conditions.

• Do Not Use:
  • In patients allergic to hyaluronic acid or peptides.
  • On areas with active infections, inflammation, or acne.
  • During pregnancy or breastfeeding.
  • In patients with autoimmune disorders or compromised immunity.

REVOFIL AQUASHINE BR SOFT FILLER Precautions and Warnings

Adhering to precautions reduces the risk of complications and ensures safe application.

• Avoid injecting into vascular-rich areas to prevent complications.
• Do not combine with other fillers or cosmetic procedures in the same session.
• Conduct a thorough medical history review to identify potential contraindications.

REVOFIL AQUASHINE BR SOFT FILLER Post-Treatment Care

Following post-treatment care recommendations optimizes results and reduces side effects.

• Aftercare Guidelines:
  • Avoid makeup application for 12 hours post-injection.
  • Refrain from excessive sun exposure, heat, or physical exertion for 48 hours.
  • Use gentle skincare products, including sunscreen with SPF 50.

REVOFIL AQUASHINE BR SOFT FILLER Side Effects and Adverse Reactions

The filler is generally well-tolerated, with mild and transient side effects.

• Common Side Effects:
  • Redness, swelling, or tenderness at injection sites.
  • Temporary bruising or slight itching.
• Rare Reactions:
  • Hypersensitivity or granuloma formation, requiring medical evaluation.

REVOFIL AQUASHINE BR SOFT FILLER Patient Eligibility

This product is suitable for adults seeking non-invasive skin rejuvenation and pigmentation correction.

• Ideal Candidates:
  • Patients over 18 years with mild to moderate signs of aging.
  • Individuals seeking hydration, radiance, and elasticity improvement.
• Not recommended for those with unrealistic expectations or severe medical conditions.

REVOFIL AQUASHINE BR SOFT FILLER Follow-Up and Maintenance

Regular treatments help maintain the product’s benefits and improve long-term skin health.

• Treatment Protocol:
  • Initial treatments: 1–2 sessions spaced 4 weeks apart.
  • Maintenance: Additional treatments every 6–12 months, depending on patient response.

REVOFIL AQUASHINE BR SOFT FILLER Manufacturer and Regulatory Information

REVOFIL AQUASHINE BR SOFT FILLER is developed by Caregen Co., Ltd., a global leader in peptide-based solutions.

• Certifications: CE-marked for quality and safety.
• Manufacturer: Caregen Co., Ltd., South Korea.
• Contact Information: Available on the official Caregen website.